Kaiqing Yang

Ms. Kaiqing Yang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
JZJinglin Zhao
Jinglin Zhao
SHShu Huang
Shu Huang
DTDingji Tan
Dingji Tan
KYKaiqing Yang
Kaiqing Yang
MCMingyue Chen
Mingyue Chen
XMXiaoqin Mao
Xiaoqin Mao
Background. While N6-methyladenosine (m6A) modification of RNA and the tumor immune microenvironment both influence the progression of cancer, little attention has been paid to interactions between these two factors. Thus, we systematically explored potential biomarkers in the malignant progression of bladder urothelial carcinoma (BLCA) via combining expression of m6A methylation regulators with tumor immune infiltration. Methods. We extracted m6A regulators from published literature, downloaded BLCA RNA-seq and clinical information from the Cancer Genome Atlas database, and integrated three main bioinformatic methods and qPCR to explore the biological variations in the malignant progression of BLCA. Results. FTO, IGF2BP3, and YTHDC1 have a significant difference in bladder cancer and prognosis. Two subgroups (clusters 1 and 2) were identified according to three key m6A regulators; cluster 1 was preferentially associated with poor prognosis and immune infiltration relative to cluster 2 significantly. We further identified PGM1 and ENO1 as potential prognostic biomarkers, as they were correlated with FTO and IGF2BP3 positively but with YTHDC1, negatively. M2 macrophage and TFH cells were highly infiltrated in BLCA and were associated with BLCA prognosis. Finally, PGM1 and ENO1 were correlated with M2 macrophage and TFH cells and their surface markers CD163and CXCR5. Conclusions. PGM1 and ENO1 are highly correlated with the malignant progression of BLCA, and the expression of these genes may be new indicators for the diagnosis and prognosis of BLCA.

1 April 2022 in Journal of Dairy Science
Verified
Journal Article
Open access
YTYichen Tian
Yichen Tian
KYKaiqing Yang
Kaiqing Yang
YSYaoqiang Shi
Yaoqiang Shi
JZJinyang Zhang
Jinyang Zhang
QHQinqin Han
Qinqin Han
YSYuzhu Song
Yuzhu Song
In recent years, food safety incidents caused by Escherichia coli have occurred and have endangered human health. Due to the complex matrix of milk samples and the long pretreatment time, the existing methods cannot quickly detect E. coli in milk samples. It is necessary to enrich the E. coli in the complex matrix to improve the detection sensitivity. The E. coli outer membrane protein A (OmpA) is widely present on the cell membrane of E. coli and may be used as a new target to enrich E. coli. In this study, the purified recombinant OmpA protein was used to immunize BALB/c mice to produce polyclonal antibody. Immunomagnetic beads were combined with the polyclonal antibody to enrich the E. coli in the artificially contaminated milk samples. The products of immunoprecipitation were further used for PCR assay. The bacteria in the PCR sample can be pre-enriched, and the limit of detection is 10 × 100 cfu/mL, which is about 100 times more sensitive than samples not processed by this method. Then, the artificially contaminated milk, coffee, juice, and soybean milk samples were tested separately, and it was found that the E. coli gene could be amplified. The whole analysis time was about 120 min, including the enrichment of bacteria and the detection of eluate. We found that OmpA combined with immunomagnetic beads was more efficient, fast, and convenient than the conventional method. Bacteria can be enriched more efficiently without extracting genomic DNA and culturing bacteria. Therefore, this method has potential value for improving the detection sensitivity and shortening the detection time of E. coli in food samples.

22 April 2026 in Gels
Verified
Journal Article
Open access
PDF file
KYKaiqing Yang
Kaiqing Yang
JZJuping Zheng
Juping Zheng
SSShiquan Shen
Shiquan Shen
CLChao Li
Chao Li
YSYuzhu Song
Yuzhu Song
YTYichen Tian
Yichen Tian
As the most abundant natural polymer on Earth, cellulose offers distinct advantages including renewability, biocompatibility, and modifiability. Among its various morphologies, spherical cellulose hydrogels (SCHs) represent a particularly versatile form ranging from micrometer to millimeter scales. They possess a unique hydrophilic 3D network, excellent flowability, high specific surface area, and outstanding mechanical stability, demonstrating great potential for biomedical applications. This mini-review highlights the primary bottom-up fabrication strategies for SCHs, including dripping, spraying, emulsion, and microfluidics, and the mechanisms by which different fabrication processes regulate their size, morphology, and structure are elucidated. On this basis, the recent advancements in SCHs across key biomedical domains, specifically in chromatographic separation, controlled drug delivery, tissue engineering, and wound healing, are discussed. Finally, the current challenges and future directions in this field are summarized and predicted, aiming to provide a reference for the development and application of high-performance cellulose-based biomaterials.